Quality of Life and Exercise Capacity in COPD

Quality of Life Clinical Trial

Official title: The Effect of Exercise Capacity on Quality of Life in COPD Patients

Status Completed

Clinical Trial Summary

COPD patients will be examined in 4 groups according to their walking distance. Patients walking under 150 meters will be determined as Group 1, those walking between 150-249 meters will be Group 2, those walking between 250-349 meters will be selected as Group 3, and patients with COPD who walk 350 and above will be determined as Group 4. The groups were compared in terms of quality of life, psychological symptoms and dyspnea.

Clinical Trial Description

Quality of life affects the mortality rate independently in patients with COPD. The treatment applied in COPD does not stop the decrease in lung function, nor does it prolong the survival time. Spirometric evaluations to determine the severity of the disease are not sufficient to explain the perception of patients and their adaptation to their diseases. Therefore, evaluating the quality of life has become an important measure of treatment in COPD patients. Quality of life measurements should be done to minimize the effect of the disease, to help patients better cope with the consequences of an incurable long-term condition, and to determine modifiable factors. Identifying modifiable factors; in personalized treatment adopted in airway diseases in recent years; it is important to be able to apply appropriate pharmacological and non-pharmacological treatments Our aim is to exercise capacity in COPD patients; firstly to investigate the effect on quality of life, then to determine the relationship between emergency admission and hospitalization, dyspnea, psychological symptoms. ;

Related Conditions & MeSH terms

• Copd
• Exercise Capacity
• Quality of Life

• NCT number: NCT04376892
• Study type: Observational
• Source: Izmir Katip Celebi University
• Status: Completed
• Start date: January 2013
• Completion date: May 2020